Cargando…
Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the...
Autores principales: | Finsterer, Josef, Scorza, Fulvio A, Scorza, Carla A, Fiorini, Ana C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788215/ https://www.ncbi.nlm.nih.gov/pubmed/35117973 http://dx.doi.org/10.5501/wjv.v11.i1.82 |
Ejemplares similares
-
Outcome of Endovascular-Treated Subarachnoid Bleeding Triggering Pulmonary and Cardiac Takotsubo
por: Finsterer, Josef, et al.
Publicado: (2020) -
Is Guillain Barre syndrome truly caused by SARS-CoV-2?
por: Finsterer, Josef, et al.
Publicado: (2021) -
Diagnosing Transient Global Amnesia Requires Exclusion of Alternative Differentials
por: Finsterer, Josef, et al.
Publicado: (2020) -
Affection of the Gastrointestinal Smooth Muscles in Myotonic Dystrophy Is Not Unusual
por: Finsterer, Josef, et al.
Publicado: (2019) -
Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
por: Finsterer, Josef, et al.
Publicado: (2020)